Skip to content
Medical Health Aged Care

GPs back Meningococcal B vaccine call

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs (RACGP) has thrown its support behind 10 Independent NSW MPs calling on the State Government to boost Meningococcal B vaccination rates. 

The push follows a similar RACGP call made earlier this year, when it urged the Government to protect families across the state by providing free Meningococcal B vaccines to at-risk groups, including children aged two-and-under, and every teen aged 15-19-years-old.   

RACGP NSW and ACT Chair, Dr Rebekah Hoffman, backed the call for action. 

“By providing the Meningococcal B vaccine free of charge for at-risk groups we can save lives across the state,” she said. 

“This is a rare but devastating disease, which can progress quickly and lead to death or disability, including young babies. Other governments have already acted to help protect families by rolling out vaccination funding programs, including South Australia, Queensland, and the Northern Territory, as well as a commitment from the Western Australian Opposition. South Australia’s Meningococcal B vaccination program cut rates amongst children by 60%, and by 73% amongst adolescents.  

“We have an effective vaccine, but we must do more to boost vaccination rates during a cost-of-living crisis. There’s never been a more important time to ensure free access to all at-risk patients.   

“This is a disease that must be taken seriously, with statistics showing it kills 5-10% of patients and leaves 10-20% of those who survive with brain damage, hearing loss or a learning disability. What is particularly disturbing is that this virus is most devastating for vulnerable kids and young people.  

“Prevention, rather than treatment in hospital, is the best solution for saving lives from Meningococcal B. By providing this vaccine for free to certain patient groups we can keep people as safe as possible from harm. There’s no need for delay, let’s save precious lives at risk.” 

~ENDS 

RACGP spokespeople are available for interviews: 03 8699 0992 / [email protected]


About us:

About the RACGP 

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians. 

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here. 


Contact details:

Media contacts 

Media team: 03 8699 0992 / [email protected] 

 

Follow us on Twitter: @RACGP and Facebook. 

 

More from this category

  • Medical Health Aged Care
  • 18/04/2025
  • 07:00
Monash University

Experts warn of increased alcohol harms over the Easter long weekend

Heavy alcohol consumption is usually associated with the summer months, not with Easter. But new analysis of Victorian ambulance data shows that there are regularly more than 500 alcohol-related attendances over the Easter long weekend. This heightened level of alcohol harm means the upcoming four-day weekend is the equivalent of four successive Saturday nights, and Victorians should consider their alcohol consumption and plan to stay safe as they prepare for Easter. The analysis reaffirms the findings of other projects led by the National Ambulance Surveillance System (NASS) at Turning Point and Monash University. VicHealth-funded research into the 2022 calendar year…

  • Contains:
  • Medical Health Aged Care
  • 17/04/2025
  • 23:26
Avania

Avania Strengthens Leadership Team With Pivotal Executive Appointments

BILTHOVEN, Netherlands & BOSTON–BUSINESS WIRE– Avania — the leading global MedTech advisory and clinical development partner — today announced the appointments of Jasmine Saba…

  • Contains:
  • Medical Health Aged Care
  • 17/04/2025
  • 22:11
Tilray Brands, Inc.

Tilray Medical Introduces Cannabis Edibles in Australia

Tilray Medical Expands Offerings with Good Supply Brand Medical Cannabis Pastilles for Australian PatientsSYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia. This launch marks Tilray Medical's first medical cannabis edible offering in the country, providing patients with a sugar-free and vegan-friendly treatment option.Denise Faltischek, Chief Strategy Officer and Head of…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.